Toll Free: 1-888-928-9744
Published: Aug, 2019 | Pages:
140 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global animal vaccines market size is expected to reach USD 13.37 billion by 2026, according to a new report by Grand View Research, Inc. expanding at a CAGR of 6.3% over the forecast period. Rise in the outbreak of livestock diseases, expanding livestock population and increasing zoonotic diseases are driving the market growth. Increasing awareness regarding commercially available vaccines is pushing the adoption globally. This market has emerged to be one of the profitable investment options seeking attention and investments from both government and non-government players. Rise in the number of pet owners and their shifting focus towards healthy animal practices are other key factors propelling the growth of the market. Government intervention in distribution channel on the other hand, is affecting the profitability of the veterinary vaccine manufacturers. The bulk purchase and supply of livestock vaccines by countries such as India and Alaska that have large livestock population are reducing the profit margins of the vaccine manufacturers’ through bulk pricing. Further Key Findings from the Report Suggest: Attenuated vaccines emerged as the largest segment as a result of the benefits such as improved effectivity and enhanced long-term prevention Cattle vaccines accounted for the largest share in the animal type segment of veterinary vaccines market owing to the rise in the demand for safe animal products Companion animal vaccines segment is the fastest growing segment owing to the increase in number of pet owners worldwide North America dominated the market with the largest share in 2018. Constantly rising awareness regarding animal health and increasing commercialization of animal products are facilitating dominance of the region during the forecast period. Asia Pacific is projected to witness swift growth during the forecast period owing to the speedy adoption of veterinary vaccines for quality food products and better animal health Key players including Zoetis, Virbac Inc. Indian Immunological Limited, Heska Corp., Boehringer Inghlem, Bayer Pharma Ag, Merck Animal Health and Biogenesis Bago dominated the global animal vaccines market.
Table of Contents Chapter 1 Research Methodology & Scope 1.1 Market Segmentation & Scope 1.1.1 Product 1.1.2 Animal type 1.1.3 Regional Scope 1.1.4 Estimates and Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased database: 1.3.2 GVR’s Internal Database 1.3.3 Secondary sources 1.3.4 Primary Research: 1.3.5 Details of Primary Research 1.3.5.1 Data for primary interviews in North america 1.3.5.2 Data for primary interviews in Europe 1.3.5.3 Data for primary interviews in Asia Pacific 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 1.6.1.1 Approach 1: Commodity Flow Approach 1.7 List of Secondary Sources 1.8 List of Primary Sources 1.9 Report Objectives Chapter 2 Executive Summary 2.1 Market Outlook 2.1.1 Animal vaccines market Outlook, 2014 - 2026 (USD Million) 2.2 Segment Outlook 2.3 Animal vaccines market Summary, 2018 Chapter 3 Animal vaccines market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent market analysis 3.1.1.1 Animal health Market Outlook, 2014 - 2026 (USD Million) 3.2 Penetration & Growth Prospect Mapping 3.3 Regulatory Framework 3.4 Animal vaccines market dynamics 3.4.1 Market driver analysis 3.4.1.1 Rise in livestock population and increasing pet ownership rates 3.4.1.2 Increase in number of disease outbreaks 3.4.1.3 Rising R&D and procedural advancements 3.4.2 Market restraint analysis 3.4.2.1 Government intervention 3.4.2.2 Short product exclusivity period 3.5 Animal vaccines market Analysis Tools: Porters 3.5.1 Supplier Power 3.5.2 Buyer Power 3.5.3 Threat Of Substitutes 3.5.4 Threat Of New Entrants 3.5.5 Competitive Rivalary 3.6 PESTEL Analysis 3.6.1 Political landscape 3.6.2 Economic landscape 3.6.3 Social landscape 3.6.4 Technology landscape 3.6.5 Legal landscape 3.7 Major Deals & Strategic Alliances Analysis 3.7.1 Mergers & Acquisitions Chapter 4 Animal vaccines market: Competitive Analysis 4.1 Market Participation Categorization 4.2 Public Companies 4.2.1 Company market position analysis 4.2.2 Competitive Dashboard Analysis 4.3 Private Companies 4.3.1 List of key emerging companies Chapter 5 Animal vaccines market: Product Estimates & Trend Analysis 5.1 Product Market Share Analysis, 2018 & 2026 5.2 Product Dashboard 5.3 Global Animal vaccines market, By Product, 2014 to 2026 5.3.1 Attenuated live vaccines 5.3.1.1 Attenuated live vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 5.3.2 Inactivated vaccines 5.3.2.1 Inactivated vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 5.3.3 Subunit vaccines 5.3.3.1 Subunit vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 5.3.4 DNA vaccines 5.3.4.1 DNA vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 5.3.5 Recombinant vaccines 5.3.5.1 Recombinant vaccines market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 6 Animal vaccines market: Animal type Estimates & Trend Analysis 6.1 Animal Type Market Share Analysis, 2018 & 2026 6.2 Animal type Market Share Analysis, 2018 & 2026 6.2.1 Animal type Dashboard 6.3 Global Animal vaccines market, by Animal type, 2014 to 2026 6.3.1 Poultry 6.3.1.1 Poultry Market by disease type 6.3.1.1.1 Infectious bronchitis 6.3.1.1.1.1 Infectious bronchitis market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.1.1.2 Avian influenza 6.3.1.1.2.1 Avian influenza market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.1.1.3 Marek’s disease 6.3.1.1.3.1 Marek’s disease market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.1.1.4 Newcastle disease 6.3.1.1.4.1 Newcastle disease market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.1.1.5 Salmonella 6.3.1.1.5.1 Salmonella market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.2 Aqua 6.3.2.1 Aqua Market by disease type 6.3.2.1.1 Streptococcosis 6.3.2.1.1.1 Streptococcosis market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.2.1.2 Vibrio 6.3.2.1.2.1 Vibrio market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.2.1.3 Aeromonas 6.3.2.1.3.1 Aeromonas market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.3 Ruminants 6.3.3.1 Ruminants Market by disease type 6.3.3.1.1 Foot & mouth disease (FMD) 6.3.3.1.1.1 Foot & mouth disease (FMD) market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.3.1.2 Lumpy skin 6.3.3.1.2.1 Lumpy skin market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.3.1.3 Rotavirus 6.3.3.1.3.1 Rotavirus market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.3.1.4 Corona virus 6.3.3.1.4.1 Corona virus drugs market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.3.1.5 E.coli 6.3.3.1.5.1 E.coli market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.3.1.6 Others 6.3.3.1.6.1 Others market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4 Companion 6.3.4.1 Canine Market by disease type 6.3.4.1.1 Distemper 6.3.4.1.1.1 Distemper market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.1.2 Kennel cough 6.3.4.1.2.1 Kennel cough market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.1.3 Parvovirus 6.3.4.1.3.1 Parvovirus market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.1.4 Canine herpes 6.3.4.1.4.1 Canine herpes drugs market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.1.5 Lyme disease 6.3.4.1.5.1 Lyme disease market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.1.6 Rabies 6.3.4.1.6.1 Rabies market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.2 Feline Market by disease type 6.3.4.2.1 Rhinotracheitis 6.3.4.2.1.1 Rhinotracheitis market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.2.2 Calcivirus 6.3.4.2.2.1 Calcivirus market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.2.3 Corona virus 6.3.4.2.3.1 Corona virus market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.2.4 Panleukopenia 6.3.4.2.4.1 Panleukopenia market estimates and forecasts, 2014 - 2026 (USD Million) 6.3.4.2.5 Rabies 6.3.4.2.5.1 Rabies market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 7 Animal vaccines market: Regional Estimates & Trend Analysis, by, Product, Animal Type 7.1 Regional Market Snapshot 7.2 Market Share Analysis by Country, 2018 7.2.1 North America 7.2.2 Europe 7.2.3 Asia Pacific 7.2.4 Latin America 7.2.5 MEA 7.3 SWOT Analysis, by Region 7.3.1 North America 7.3.2 Europe 7.3.3 Asia Pacific 7.3.4 Latin America 7.3.5 Middle East and Africa 7.4 North America 7.4.1 North America Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.4.2 U.S. 7.4.2.1 U.S. Animal vaccines market estimates and forecasts, 2014 - 2026(USD Million) 7.4.3 Canada 7.4.3.1 Canada Animal vaccines market estimates and forecasts, 2014 - 2026(USD Million) 7.5 Europe 7.5.1 Europe Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.5.2 UK 7.5.2.1 UK Animal vaccines market estimates and forecasts, 2014 - 2026(USD Million) 7.5.3 Germany 7.5.3.1 Germany Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.6 Asia Pacific 7.6.1 Asia Pacific Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.6.2 Japan 7.6.2.1 Japan Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.6.3 China 7.6.3.1 China Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.6.4 India 7.6.4.1 India Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.6.5 Australia 7.6.5.1 Australia Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.7 Latin America 7.7.1 Latin America Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.7.2 Brazil 7.7.2.1 Brazil Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.7.3 Mexico 7.7.3.1 Mexico Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.7.4 Argentina 7.7.4.1 Argentina Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.8 MEA 7.8.1 MEA Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.8.2 Africa 7.8.2.1 Africa Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) 7.8.3 Saudi Arabia 7.8.3.1 Saudi Arabia Animal vaccines market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 8 Company Profiles 8.1 Merck & Co., Inc. 8.1.1 Company Overview 8.1.2 Financial Performance 8.1.3 Product Benchmarking 8.1.4 Strategic Initiatives 8.2 Zoetis 8.2.1 Company Overview 8.2.2 Financial Performance 8.2.3 Product Benchmarking 8.2.4 Strategic Initiatives 8.3 Boehringer Ingelheim International GmbH 8.3.1 Company Overview 8.3.2 Financial Performance 8.3.3 Product Benchmarking 8.3.4 Strategic Initiatives 8.4 Virbac, Inc. 8.4.1 Company Overview 8.4.2 Financial Performance 8.4.3 Product Benchmarking 8.4.4 Strategic Initiatives 8.5 Biogénesis Bagó S.A. 8.5.1 Company Overview 8.5.2 Financial Performance 8.5.3 Product Benchmarking 8.5.4 Strategic Initiatives 8.6 Indian Immunologicals Limited 8.6.1 Company Overview 8.6.2 Financial Performance 8.6.3 Product Benchmarking 8.6.4 Strategic Initiatives 8.7 Elanco 8.7.1 Company Overview 8.7.2 Financial Performance 8.7.3 Product Benchmarking 8.7.4 Strategic Initiatives 8.8 Ceva 8.8.1 Company Overview 8.8.2 Financial Performance 8.8.3 Product Benchmarking 8.8.4 Strategic Initiatives 8.9 Phibro Animal Health Corporation 8.9.1 Company Overview 8.9.2 Financial Performance 8.9.3 Product Benchmarking 8.9.4 Strategic Initiatives 8.10 Neogen Corporation 8.10.1 Company Overview 8.10.2 Financial Performance 8.10.3 Product Benchmarking 8.10.4 Strategic Initiatives
List of Tables TABLE 1 North America animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 2 North America animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 3 U.S. animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 4 U.S. animal vaccines market, by animal type, 2014 - 2026 (USD million) TABLE 5 Canada animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 6 Canada animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 7 Europe animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 8 Europe animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 9 U.K. animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 10 U.K. animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 11 Germany animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 12 Germany animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 13 Asia Pacific animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 14 Asia Pacific animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 15 Japan animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 16 Japan animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 17 China animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 18 China animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 19 India animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 20 India animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 21 Australia animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 22 Australia animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 23 Latin America animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 24 Latin America animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 25 Brazil animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 26 Brazil animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 27 Mexico animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 28 Mexico animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 29 Argentina animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 30 Argentina animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 31 MEA animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 32 MEA animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 33 South Africa animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 34 South Africa animal vaccines market, by animal type, 2014 - 2026 (USD Million) TABLE 35 Saudi arabia animal vaccines market, by product, 2014 - 2026 (USD Million) TABLE 36 Saudi arabia animal vaccines market, by animal type, 2014 - 2026 (USD Million) List of Figures FIG. 1 Market segmentation FIG. 2 Market research process FIG. 3 Data triangulation techniques FIG. 4 Primary research pattern FIG. 5 Primary interviews in North America FIG. 6 Primary interviews in Europe FIG. 7 Primary interviews in Asia Pacific FIG. 8 Market research approaches FIG. 9 Value-chain-based sizing & forecasting FIG. 10 QFD modeling for market share assessment FIG. 11 Market formulation & validation FIG. 12 Commodity flow analysis FIG. 13 Animal vaccines market revenue, 2014 - 2026 (USD Million) FIG. 14 Animal vaccines market snapshot FIG. 15 Animal health market revenue, 2014 - 2026 (USD Million) FIG. 16 Penetration & growth prospect mapping FIG. 17 Animal vaccines market dynamics FIG. 18 Animal vaccines market driver impact FIG. 19 Animal vaccines market restraint impact FIG. 20 Market participant categorization FIG. 21 Company market position analysis FIG. 22 Competitive dashboard analysis FIG. 23 Animal vaccines market: Product movement analysis FIG. 24 Animal vaccines market product dashboard FIG. 25 Animal vaccines market by animal type FIG. 26 Global attenuated live vaccines market, 2014 - 2026 (USD Million) FIG. 27 Global inactivated vaccines market, 2014 - 2026 (USD Million) FIG. 28 Global subunit vaccines market, 2014 - 2026 (USD Million) FIG. 29 Global DNA vaccines market, 2014 - 2026 (USD Million) FIG. 30 Global recombinant vaccines market, 2014 - 2026 (USD Million) FIG. 31 Animal vaccines market: Animal type movement analysis FIG. 32 Veterinary vaccines Animal type dashboard FIG. 33 Animal vaccines market by animal type FIG. 34 Global infectious bronchitis market, 2014 - 2026 (USD Million) FIG. 35 Global avian influenza market, 2014 - 2026 (USD Million) FIG. 36 Global Marek’s diseasemarket, 2014 - 2026 (USD Million) FIG. 37 Global marek’s disease market, 2014 - 2026 (USD Million) FIG. 38 Global newcastle disease market, 2014 - 2026 (USD Million) FIG. 39 Global salmonella market, 2014 - 2026 (USD Million) FIG. 40 Global streptococcosis market, 2014 - 2026 (USD Million) FIG. 41 Global vibrio market, 2014 - 2026 (USD Million) FIG. 42 Global aeromonas market, 2014 - 2026 (USD Million) FIG. 43 Global aeromonas market, 2014 - 2026 (USD Million) FIG. 44 Global foot & mouth disease (FMD) market, 2014 - 2026 (USD Million) FIG. 45 Global lumpy skin market, 2014 - 2026 (USD Million) FIG. 46 Global Rotavirusmarket, 2014 - 2026 (USD Million) FIG. 47 Global rotavirus market, 2014 - 2026 (USD Million) FIG. 48 Global corona virus drugs market, 2014 - 2026 (USD Million) FIG. 49 Global e.coli market, 2014 - 2026 (USD Million) FIG. 50 Global others market, 2014 - 2026 (USD Million) FIG. 51 Global distemper market, 2014 - 2026 (USD Million) FIG. 52 Global kennel cough market, 2014 - 2026 (USD Million) FIG. 53 Global Parvovirusmarket, 2014 - 2026 (USD Million) FIG. 54 Global parvovirus market, 2014 - 2026 (USD Million) FIG. 55 Global canine herpes drugs market, 2014 - 2026 (USD Million) FIG. 56 Global lyme disease market, 2014 - 2026 (USD Million) FIG. 57 Global rabies market, 2014 - 2026 (USD Million) FIG. 58 Global rhinotracheitis market, 2014 - 2026 (USD Million) FIG. 59 Global calcivirus market, 2014 - 2026 (USD Million) FIG. 60 Global corona virus market, 2014 - 2026 (USD Million) FIG. 61 Global corona virus market, 2014 - 2026 (USD Million) FIG. 62 Global panleukopenia market, 2014 - 2026 (USD Million) FIG. 63 Global rabies market, 2014 - 2026 (USD Million) FIG. 64 Regional market place: Key takeaways FIG. 65 North America animal vaccines market share by countries, 2018 FIG. 66 Europe animal vaccines market share by countries, 2018 FIG. 67 Asia Pacific animal vaccines market share by countries, 2018 FIG. 68 Latin America animal vaccines market share by countries, 2018 FIG. 69 MEA animal vaccines market share by countries, 2018 FIG. 70 Regional outlook, 2018 &2026 FIG. 71 North America animal vaccines market, 2014 - 2026 (USD Million) FIG. 72 U.S. animal vaccines market, 2014 - 2026 (USD Million) FIG. 73 Canada animal vaccines market, 2014 - 2026 (USD Million) FIG. 74 Europe animal vaccines market, 2014 - 2026 (USD Million) FIG. 75 UK animal vaccines market, 2014 - 2026 (USD Million) FIG. 76 Germany animal vaccines market, 2014 - 2026 (USD Million) FIG. 77 Asia Pacific animal vaccines market, 2014 - 2026 (USD Million) FIG. 78 Japan animal vaccines market, 2014 - 2026 (USD Million) FIG. 79 China animal vaccines market, 2014 - 2026 (USD Million) FIG. 80 India animal vaccines market, 2014 - 2026 (USD Million) FIG. 81 Australia animal vaccines market, 2014 - 2026 (USD Million) FIG. 82 Latin America animal vaccines market, 2014 - 2026 (USD Million) FIG. 83 Brazil animal vaccines market, 2014 - 2026 (USD Million) FIG. 84 Mexico animal vaccines market, 2014 - 2026 (USD Million) FIG. 85 Argentina animal vaccines market, 2014 - 2026 (USD Million) FIG. 86 MEA animal vaccines market, 2014 - 2026 (USD Million) FIG. 87 Africa animal vaccines market, 2014 - 2026 (USD Million) FIG. 88 Saudi Arabia animal vaccines market, 2014 - 2026 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.